Paul Surdez
Investor Relations Contact chez CATALENT, INC.
Profil
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Postes actifs de Paul Surdez
| Sociétés | Poste | Début |
|---|---|---|
| CATALENT, INC. | Investor Relations Contact | 07/01/2020 |
Anciens postes connus de Paul Surdez
| Sociétés | Poste | Fin |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Investor Relations Contact | - |
| COVANCE INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| CATALENT, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
